Post
Featured

With Musk making a move, satellite phone niche leader $ASTS had its price target cut by 45% and closed down 8.27%. On the pharmaceutical side, $SNDX 's trial failed, sending its stock plunging 17.28% in one day. Meanwhile, AI giants are starting to pay people's electricity bills: $ORCL closed up 4.43%, while Fermi rose 19.85%🦈 October 13 U.S. stock market closing brief👇


#美股 #ASTS #甲骨文
View Original
post-image
This page contains third-party content and does not constitute any advice, nor does it represent Gate's endorsement of such views. For details, please see disclaimer.
ASTSASTS-4.07%
ORCLORCL-3.42%

  • 1

Add a comment
Add a comment

Comment
NFTAirdropResident
2 days ago
SNDX dropping 17% in one day is brutal, biotech really is high risk, high reward—whether you’re seeking riches or a scare is hard to say
0View Original
TD9_Sequencer
3 days ago
$ORCL covering other people's electricity bills is a pretty wild move—the AI computing arms race has entered a new phase of burning through cash
0View Original
FactorHunter
3 days ago
ASTS has been laid flat after being singled out by Musk—how much longer can the satellite communications story last?
0View Original
TheMasterOfChasingGainsAnd
3 days ago
First Review
Impressive 💡
0View Original